Skip to content

News Category: Health & Medical

PMB Announces EIT Health Supported FLASHKNiFE Consortium Towards the Clinical Application of FLASH Radiation Therapy

By asianet

PMB announces the launch of the FLASHKNiFE Consortium, supported by the European Institute of Innovation & Technology for Health (EIT Health). This European public-private partnership aims at advancing radiation therapy by introducing a new radiotherapy device into clinical practice. More than 10 million patients receive radiation therapy each year worldwide, making it an essential tool … Continued

Tau-targeting Alzheimer’s treatment, HMTM, moving toward regulatory submission based on initial data from TauRx’s LUCIDITY trial

By asianet

– LUCIDITY data suggest that participants receiving hydromethylthionine mesylate (HMTM) decline at a rate substantially less than is typical in Alzheimer’s based on published research – Safety profile is favourable and consistent with previous HMTM studies – TauRx will now pursue regulatory submission and coverage for HMTM TauRx Pharmaceuticals Ltd, the global leader in tau-based … Continued

MedAlliance’s SELUTION SLR Drug-Eluting Balloon (DEB) Receives FDA Investigational Device Exemption (IDE) Approval, Making it the First Limus DEB to be Available to US Patients

By asianet

The SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained drug release, similar to a drug-eluting stent (DES). SELUTION SLR was also the first DEB (Drug Eluting Balloon) granted “breakthrough device designation” by the FDA on March 4, 2019 and further in September 25, 2019 for below-the-knee (BTK) indications … Continued

Menarini inaugurates new regional headquarters in Dubai, UAE

By asianet

The pharmaceutical group, present in 140 countries in the world, aims to raise standard of patient healthcare across the Middle East and Africa (MEA) region with innovative products and breakthrough research Menarini, the leading Italian pharmaceutical group founded in 1886, today opened its regional headquarters in Dubai Science Park as part of its goal to … Continued

Pierre Fabre and EORTC open a large Phase III clinical study in the adjuvant setting of stage IIB-C melanoma

By asianet

– First study conducted in the adjuvant setting with a combination of BRAF and MEK inhibitors in high-risk stage II BRAF V600E/K-mutant cutaneous melanoma – A global partnership between EORTC and Pierre Fabre to advance research in melanoma Pierre Fabre and the European Organisation for Research and Treatment of Cancer (EORTC) today announced the screening … Continued

Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment

By asianet

-Insilico’s candidate demonstrated a favorable profile with good in vivo efficacy at low doses, efficient synthesis, and no need for co-administration with Ritonavir. -The candidate is intended to be used for the treatment of SARS-CoV-2 and its variants, along with other coronaviruses. -Insilico’s candidate has a novel structure that can be synthesized efficiently, designed by … Continued

UAE powerhouse VPS Healthcare launches Burjeel Holdings to scale the next generation of its growth

By asianet

On the sidelines of the World Economic Forum Annual Meeting, the UAE-based private healthcare services platform commits 50 pediatric stem cell transplantations to refugees of the Ukraine conflict The UAE-based VPS Healthcare has announced the launch of Burjeel Holdings on the sidelines of the World Economic Forum Annual Meeting in Davos on Sunday to consolidate … Continued

Fullerton Health Chronicles COVID-19 Journey in E-book

By asianet

Fullerton Health has today released ‘The Mighty Storm – Fullerton Health Rises to the Challenge’, a 68-page e-book that chronicles Fullerton Health’s struggles, challenges and successes in support of the nation’s two-year fight against the pandemic. The e-book tells the Fullerton Health COVID-19 story from the perspectives of Fullerton Health’s doctors, nurses, corporate employees and … Continued

OptraSCAN’s Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time

By asianet

OptraSCAN(R) [https://www.optrascan.com/], the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent – No 2020/0334814 A1 by the United States Patent and Trademark Office. OS-SiA has inbuilt intelligence to scan, index and analyze pathological samples simultaneously. This will benefit the end-user to view the whole slide scanned … Continued